| Literature DB >> 35774590 |
Farhan Raza1, Callyn Kozitza2, Chris Lechuga3, Daniel Seiter4, Philip Corrado4, Mohammed Merchant1, Naga Dharmavaram1, Claudia Korcarz1, Marlowe Eldridge5, Christopher Francois6, Oliver Wieben3, Naomi Chesler4.
Abstract
Deep phenotyping of pulmonary hypertension (PH) with multimodal diagnostic exercise interventions can lead to early focused therapeutic interventions. Herein, we report methods to simultaneously assess pulmonary impedance, differential biventricular myocardial strain, and right ventricular:pulmonary arterial (RV:PA) uncoupling during exercise, which we pilot in subjects with suspected PH. As proof-of-concept, we show that four subjects with different diagnoses [pulmonary arterial hypertension (PAH); chronic thromboembolic disease (CTEPH); PH due to heart failure with preserved ejection fraction (PH-HFpEF); and noncardiac dyspnea (NCD)] have distinct patterns of response to exercise. RV:PA coupling assessment with exercise was highest-to-lowest in this order: PAH > CTEPH > PH-HFpEF > NCD. Input impedance (Z0) with exercise was highest in precapillary PH (PAH, CTEPH), followed by PH-HFpEF and NCD. Characteristic impedance (ZC) tended to decline with exercise, except for the PH-HFpEF subject (initial Zc increase at moderate workload with subsequent decrease at higher workload with augmentation in cardiac output). Differential myocardial strain was normal in PAH, CTEPH, and NCD subjects and lower in the PH-HFpEF subject in the interventricular septum. The combination of these metrics allowed novel insights into mechanisms of RV:PA uncoupling. For example, while the PH-HFpEF subject had hemodynamics comparable to the NCD subject at rest, with exercise coupling dropped precipitously, which can be attributed (by decreased myocardial strain of interventricular septum) to poor support from the left ventricle (LV). We conclude that this deep phenotyping approach may distinguish afterload sensitive vs. LV-dependent mechanisms of RV:PA uncoupling in PH, which may lead to novel therapeutically relevant insights.Entities:
Keywords: RV:PA uncoupling; exercise hemodynamics; myocardial strain; pulmonary impedance; right ventricular pressure volume loops
Year: 2022 PMID: 35774590 PMCID: PMC9228647 DOI: 10.1093/function/zqac022
Source DB: PubMed Journal: Function (Oxf) ISSN: 2633-8823
Figure 1.Representative figure of methodology and subject phenotypes. (A) and (B). Invasive cardiopulmonary exercise test and right ventricular pressure–volume loops, at rest and with exercise. (C) Representative pressure volume loops for PH-HFpEF subject. (D) RV:PA coupling at rest and different levels of exercise (end systolic elastance: Ees to effective arterial elastance: Ea ratio). (E) Input impedance (Z0) at rest and with exercise. (F) Characteristic impedance (ZC) at rest and with exercise.
1. Baseline characteristics, hemodynamics, and myocardial strain
| Subject | 1 | 2 | 3 | 4 | ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| ||||
| Age | 70 | 66 | 66 | 63 | ||||
| Sex | F | F | M | F | ||||
| BMI (kg/m2) | 23.6 | 25.7 | 25.1 | 34.0 | ||||
| KCCQ-23 score | 52 | 80 | 62 | 96 | ||||
| BNP (pg/mL) | 134 | 91 | 112 | 40 | ||||
|
| ||||||||
| Rest | Ex | Rest | Ex | Rest | Ex | Rest | Ex | |
|
| ||||||||
| Ees (mmHg/mL) | 0.32 | 0.51 | 0.86 | 0.91 | 0.39 | 0.60 | 0.47 | 0.69 |
| Ea (mmHg/mL) | 0.76 | 1.20 | 0.97 | 1.17 | 0.27 | 0.63 | 0.41 | 0.57 |
| Ees:Ea | 0.43 | 0.43 | 0.89 | 0.78 | 1.45 | 0.95 | 1.14 | 1.20 |
| EDPVR (mmHg/mL) | 0.04 | 0.09 | 0.11 | 0.13 | 0.02 | 0.14 | 0.04 | 0.06 |
| EDPVR single beat method, β (⋅) | 5.6 | 5.8 | 5.8 | 5.9 | 5.5 | 6.3 | 5.7 | 5.8 |
| Tau (m/s) | 37 | 37 | 40 | 27 | 26 | 30 | 36 | 38 |
| RVEF (%) ‡ | 58.1 | 48.6 | 47.5 | 50.8 | 66.7 | 55.7 | 61.5 | 69.2 |
|
| ||||||||
| Zc (mmHg/L/min) | 0.38 | 0.36 | 0.30 | 0.16 | 0.37 | 0.21 | 0.18 | 0.07 |
| Z0 (mmHg/L/min) | 9.5 | 7.4 | 8.6 | 6.8 | 2.9 | 4.4 | 2.9 | 2.6 |
|
| ||||||||
|
| ||||||||
| Peak VO2 [mL/kg/min], (%) | 8.9 (45%) | 16.2 (74%) | 16.0 (65%) | 16.9 (78%) | ||||
| Peak O2 pulse (mL/beat) | 6.7 | 16.2 | 12.7 | 14.4 | ||||
| Peak watts (W) | 30 | 100 | 110 | 75 | ||||
| RER | 1.05 | 1.02 | 1.07 | 1.20 | ||||
| Peak VE/VCO2 | 43 | 36 | 34 | 25 | ||||
| Peak ETCO2 (mmHg) | 29 | 34 | 31 | 41 | ||||
| Breathing reserve (%) | 74 | 65 | 54 | 55 | ||||
|
| ||||||||
| Rest heart rate | 68 | 71 | 56 | 88 | ||||
| Rest RAP (mmHg) | 12 | 11 | 6 | 6 | ||||
| Rest PAP (mmHg) | 70/27 (38) | 34/19 (26) | 23/12 (15)† | 26/12 (18) | ||||
| Rest PAWP (mmHg) | 12 | 12 | 10 | 10 | ||||
| Rest cardiac output (L/min) | 3.95 | 3.38 | 4.69 | 6.03 | ||||
| Rest stroke volume Index (mL/m2) | 37.5 | 26.8 | 42.5 | 39.0 | ||||
| Rest PVR (WU) | 6.6 | 4.1 | 1.1 | 1.3 | ||||
|
| ||||||||
| Peak heart rate | 85 | 129 | 84 | 121 | ||||
| Peak RAP (mmHg) | 12 | 17 | 14 | 16 | ||||
| Peak PAP (mmHg) | 78/28 (48) | 76/40 (54) | 56/26 (34) | 36/23 (29) | ||||
| Peak PAWP (mmHg) | 15 | 20 | 26 | 18 | ||||
| Peak cardiac output (L/min) | 7.15 | 9.25 | 9.40 | 12.60 | ||||
| Peak stroke volume index (mL/m2) | 54.3 | 40.3 | 56.8 | 59.2 | ||||
| mPAP/CO slope (mmHg/L/min) | 3.4 | 5.3 | 5.2 | 2.1 | ||||
| Exercise TPR (mmHg/L/min) | 6.7 | 5.8 | 3.6 | 2.3 | ||||
| PAWP/CO slope (mmHg/L/min) | 0.9 | 1.7 | 2.8 | 1.5 | ||||
| Distensibility (%/mmHg) | 0.71 | 0.53 | 0.63 | 0.84 | ||||
|
| ||||||||
|
| ||||||||
| Global LV (%) | 38.1 | 27.8 | 22.3 | 30.6 | ||||
| IVS (%) | 24.1 | 15.6 | 12.7 | 30.0 | ||||
| RV free wall (%) | 15.5 | 17.2 | 31.2 | 45.0 | ||||
|
| ||||||||
| Global LV (%) | −19.1 | −19.2 | −16.0 | −16.5* | ||||
| IVS (%) | −19.3 | −19.6 | −14.8 | −16.7* | ||||
| RV free wall (%) | −28.4 | −22.6 | −18.8 | −22.4* | ||||
Peak exercise stage for subjects: #1 25W, #2 75, #3 75, and #4 50.
*Mild obesity contributing to limitation of image quality.
†Exercise hemodynamics: PAP 61/26 (42) PAWP 26 CO 9.68.
‡ Rest cardiac MRI data used for volume calibration for rest pressure volume-loop data.
Abbreviations: PAH: pulmonary arterial hypertension, CTEPH: chronic thromboembolic pulmonary hypertension, PH-HFpEF: pulmonary hypertension due to heart failure with preserved ejection fraction, NCD: noncardiac dyspnea, BMI: body mass index, KCCQ: Kansas City Cardiomyopathy Questionnaire, BNP: Brain natriuretic peptide, Ex: exercise, Ees: end-systolic elastance, Ea: effective arterial elastance, EDPVR: end-diastolic pressure volume relationship, Tau: time constant of RV relaxation, RVEF: right ventricular ejection fraction, Zc: characteristic impedance, Z0: input impedance, CPET: cardiopulmonary exercise test, VO2: oxygen consumption, RER: respiratory exchange ratio, VE/VCO2: minute ventilation-carbon dioxide slope, ETCO2: end-tidal pressure of carbon dioxide, RAP: right atrial pressure, PAP: pulmonary artery pressure, PAWP: pulmonary artery wedge pressure, PVR: pulmonary vascular resistance, CO: cardiac output, TPR: transpulmonary resistance, LV: left ventricle, IVS: interventricular septum, and RV: right ventricle.